Skip to main content
Equibles
CERT logo

CERT · Certara, Inc.

Track CERT — free

Use CERT with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about CERT

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$8.00 -0.15 (-1.84%) At close · Aug 14
Customer concentration — top 10 customers 24% of revenue

10 customers — 24% of revenue (the year ended December 31, 2025)

“Our ten largest customers accounted for 24% of revenues for the year ended December 31, 2025.”
View the 10-K filed Feb 26, 2026
Market Cap
$1.22B
Shares
152.54M

Certara, Inc. Earnings Call Transcripts

Every quarterly earnings call for Certara, Inc. (CERT) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲14.5% $84.70M $3.94M '22 Q3 22-11-07 ▲15% $86.63M $9.17M '22 Q4 23-03-01 ▲10.7% $90.30M $1.36M '23 Q1 23-05-08 ▲9.3% $90.45M $4.71M '23 Q2 23-08-09 ▲1% $85.58M −$48.97M '23 Q3 23-11-08 ▲1.6% $88.01M −$12.46M '23 Q4 24-02-29 ▲7% $96.65M −$4.68M '24 Q1 24-05-07 ▲3.2% $93.31M −$12.57M '24 Q2 24-08-06 ▲10.8% $94.82M −$1.37M '24 Q3 24-11-06 ▲14% $100.36M $6.58M '24 Q4 25-02-26 ▲9.7% $106.00M $4.74M '25 Q1 25-05-05 ▼1% $92.36M −$1.97M '25 Q2 25-08-06 ▲10.3% $104.62M $1.52M '25 Q3 25-11-06 ▲15.4% $115.86M −$5.89M '25 Q4 26-02-26 ▲0.9% $106.92M −$8.76M '26 Q1 26-05-11 LATEST ▲1% $93.27M −$55.27M '26 Q2 26-08-04
Earnings call
FY26 · Q2
2026-08-04
Certara Second Quarter 2026 Earnings Conference Call
Positive tone Software bookings momentum Services revenue softness and go-to-market reset Regulatory tailwinds and policy engagement
Revenue
$93.27M
▲ 1% YoY
Diluted EPS
$-0.36
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-03
Jefferies Global Healthcare Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-11
Certara, Inc. Q1 FY2026 Earnings Call
Positive tone Competitive risk from large pharma build-out Legacy assets and competitive moat Partnerships and ecosystem
Revenue
$106.92M
▲ 0.9% YoY
Diluted EPS
$-0.06
▼ 300% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-26
Certara, Inc. Q4 FY2025 Earnings Call
Positive tone AI and model-informed drug development (MIDD) opportunity 2026 financial guidance and margin compression Software business and product launches
Revenue
$115.86M*
▲ 15.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Certara, Inc. Q3 FY2025 Earnings Call
Positive tone Software momentum and product launches QSP and biosimulation adoption Bookings shortfall and guidance narrowing
Revenue
$104.62M
▲ 10.3% YoY
Diluted EPS
$0.01
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-06
Certara, Inc. Q2 FY2025 Earnings Call
Positive tone Biosimulation software strength (Simcyp, QSP) Regulatory milestones and EMA qualification Margins and investment cadence
Revenue
$92.36M
▼ 1% YoY
Diluted EPS
$-0.01
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-05
Certara, Inc. Q1 FY2025 Earnings Call
Positive tone FDA phase-out of animal testing and Non-Animal Navigator Headwinds and tailwinds in the market AI and Certara Cloud platform
Revenue
$106.00M
▲ 9.7% YoY
Diluted EPS
$0.03
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-26
Certara, Inc. Q4 FY2024 Earnings Call
Positive tone 2025 guidance and assumptions Software bookings and growth momentum Discovery biosimulation expansion
Revenue
$100.36M*
▲ 14% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-06
Certara, Inc. Q3 FY2024 Earnings Call
Balanced tone Biosimulation demand and strategy Customer tier dynamics and bookings Chemaxon acquisition and integration
Revenue
$94.82M
▲ 10.8% YoY
Diluted EPS
$-0.01
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-06
Certara, Inc. Q2 FY2024 Earnings Call
Balanced tone Software segment strength Services demand softness and Tier 1 caution Bookings growth
Revenue
$93.31M
▲ 3.2% YoY
Diluted EPS
$-0.08
▼ 366.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
Certara, Inc. Q1 FY2024 Earnings Call
Positive tone Guidance and outlook Software growth End market and biotech funding
Revenue
$96.65M
▲ 7% YoY
Diluted EPS
$-0.03
▼ 400% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-29
Certara, Inc. Q4 FY2023 Earnings Call
Positive tone Technology-enabled services recovery Biosimulation and MIDD market adoption Investment spend and 2024 margin
Revenue
$88.01M*
▲ 1.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-08
Certara, Inc. Q3 FY2023 Earnings Call
Revenue
$85.58M
▲ 1% YoY
Diluted EPS
$-0.31
▼ 1650% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-09
Certara, Inc. Q2 FY2023 Earnings Call
Revenue
$90.45M
▲ 9.3% YoY
Diluted EPS
$0.03
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-08
Certara, Inc. Q1 FY2023 Earnings Call
Revenue
$90.30M
▲ 10.7% YoY
Diluted EPS
$0.01
▲ 0% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-01
Certara, Inc. Q4 FY2022 Earnings Call
Revenue
$86.63M*
▲ 15% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-07
Certara, Inc. Q3 FY2022 Earnings Call
Revenue
$84.70M
▲ 14.5% YoY
Diluted EPS
$0.02
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-09
Certara, Inc. Q2 FY2022 Earnings Call
Revenue
$82.76M
▲ 18.1% YoY
Diluted EPS
$0.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
Certara, Inc. Q1 FY2022 Earnings Call
Revenue
$81.55M
▲ 22.2% YoY
Diluted EPS
$0.01
▲ 0% YoY
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-01
Certara, Inc. Q4 FY2021 Earnings Call
Revenue
$75.35M*
▲ 16.6% YoY
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-09
Certara, Inc. Q3 FY2021 Earnings Call
Revenue
$73.94M
▲ 22.6% YoY
Diluted EPS
$-0.01
▼ 200% YoY
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-05
Certara, Inc. Q2 FY2021 Earnings Call
Revenue
$70.10M
▲ 14.7% YoY
Diluted EPS
$-0.02
▼ 200% YoY
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-06
Certara, Inc. Q1 FY2021 Earnings Call
Revenue
$66.72M
▲ 16.1% YoY
Diluted EPS
$0.01
▲ 0% YoY
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-04
Certara, Inc. Q4 FY2020 Earnings Call
Revenue
$64.64M*
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–24 of 24 earnings calls
Key facts CIK 1827090 CUSIP 15687V109 13F (30d) 240 filings 225 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)